Funding and reimbursement


Most medical technologies are paid for by Public Health Authorities, usually within a third-party payer system. 

Each European market has its own unique characteristics: in some countries, budgeting and reimbursement decisions are made by regional authorities while in others these are made at national level. Certain countries have separate systems for reimbursement for hospital and community care sectors, and the amount paid for services might differ even within a country. It is challenging to navigate this complex system and medtech companies need to know both the decision-making process and how to engage with key stakeholders.

Amongst other, medtech companies need to know what reimbursement and funding mechanisms are in place, what the requirements to obtain such reimbursements are, and what health authorities, patients, and citizens are willing to pay for. In the medical technology sector, this means understanding payment and reimbursement systems, local policy environments and how healthcare systems are organised. 

MedTech Europe and Funding & Reimbursement 
Medtech Europe is currently partnering with several stakeholders, particularly with payers, to set up a platform for an open dialogue on funding and reimbursement. On the cross border care front, we closely follow the implementation of the EU Cross-Border Healthcare Directive to evaluate its impact on patients’ mobility and better understand the impact on reimbursement provisions.

Position paper

Position paper on a patient-centred affordable and sustainable system for incontinence aids

Incontinence currently affects millions of Europeans and, as our populations grow older, it will touch the lives of millions more. While Member States are responsible for the funding and delivery of health services, the EU can play an important role in improving patient care in this field by embedding key principles in health systems across Europe.

The purpose of the paper is to raise awareness, initiate and facilitate constructive dialogues amongst all stakeholders including patients, clinicians, payers, policy makers, the industry, and promote efficient collaboration in finding the best potential solutions for incontinence aids.
Position paper

Medical Technology Registries: Six Key Principles

In this paper MedTech Europe suggests six key principles that should apply when European public health authorities request to collect registry/real-world data through means of registries to inform healthcare decisions (e.g. reimbursement, coverage with evidence development, population/sub-population access). We believe that by following these principles, applicable European regulations and national laws, the quality, acceptability, efficiency of collecting and analysing this data can improve research and decision making.
Position paper

MedTech Europe Position on Community Care

This paper looks at how community care can help to address these challenges. A shift from hospital-based to community care for certain categories of patient could help deliver vital support. Hospitals can be expensive, impersonal and risky places in which to deliver care that does not require a high-tech and specialised environment. In addition, many patients and their families prefer community-based treatment.